SAR405838: A Novel and Potent Inhibitor of the MDM2:p53 Axis for the Treatment of Dedifferentiated LiposarcomaKate Lynn J. Bill, Raphael E. Pollock, Jeannine Garnett et al.|Clinical Cancer Research|2015Cited by 106
Efficacy of the MDM2 Inhibitor SAR405838 in Glioblastoma Is Limited by Poor Distribution Across the Blood–Brain BarrierMinjee Kim, Jann N. Sarkaria, Isabelle Meaux et al.|Molecular Cancer Therapeutics|2018Cited by 40
Data from Efficacy of the MDM2 Inhibitor SAR405838 in Glioblastoma Is Limited by Poor Distribution Across the Blood–Brain BarrierMinjee Kim, Jann N. Sarkaria, J. Daniel et al.|Unknown|2023Cited by 0